SCHEMBL28807641

SCHEMBL28807641

O=C(NC(Cc1ccccc1)C(=O)O)c1ncc2c(cc(-c3ccccc3)c(=O)n2CCc2ccccc2)c1O

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12503277 0.91 EGLN1 (0.77) EGLN1
SCHEMBL12503281 0.91 EGLN1 (0.77) EGLN1
SCHEMBL28964305 0.86 EGLN1 (0.84) EGLN1
SCHEMBL27951478 0.85 EGLN1 (0.74) EGLN1
SCHEMBL28807628 0.84 EGLN1 (0.83) EGLN1
SCHEMBL12502566 0.83 EGLN1 (1.00) EGLN1
SCHEMBL12502373 0.82 EGLN1 (0.71) EGLN1
SCHEMBL28809535 0.81 EGLN1 (0.84) EGLN1
SCHEMBL27951502 0.81 EGLN1 (0.90) EGLN1
SCHEMBL28947546 0.81 EGLN1 (0.88) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103608346-A Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase FIBROGEN INC 2014-02-26 CN disclosed